SCM
BLUE

Segantii Capital Management’s bluebird bio BLUE Stock Holding History

Segantii Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-31
Closed -$36K – 85
2017
Q1 		$36K Buy
+31
New +$31.6K 0.01% 322

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Segantii Capital Management's BLUE Position: Q2 2017 in Review

Segantii Capital Management sold out of bluebird bio (BLUE) in Q2 2017, closing a stake of 31 shares — an estimated $36K sold.

Segantii Capital Management first reported a position in BLUE in Q1 2017 and held it in 1 quarter. The position peaked at $36K in Q1 2017. 241 funds tracked by Wall St. Rank hold BLUE as of Q2 2017.

  • Segantii Capital Management reported no remaining bluebird bio position as of Q2 2017 after selling out during the quarter.
  • Segantii Capital Management sold 31 bluebird bio shares in Q2 2017, an estimated $36K.
  • Segantii Capital Management first reported a position in bluebird bio in Q1 2017 and held it in 1 quarter.
  • Segantii Capital Management's bluebird bio position peaked at $36K in Q1 2017.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q2 2017.

Based on Segantii Capital Management's 13F filing for Q2 2017, filed 2 Aug 2017.